Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9358240 Treprostinil administration by inhalation

Patent 9358240 was granted and assigned to United Therapeutics on June, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert Voswinckel0

Thomas Schmehl0

Werner Seeger0

Carl Sterritt0

Horst Olschewski0

Lewis J. Rubin0

Robert Roscigno0

Date of Patent

June 7, 2016

0

Patent Application Number

125912000

Date Filed

November 12, 2009

0

Patent Citations Received

US Patent 11712442 Dry powder treprostinil for the treatment of pulmonary hypertension

0

US Patent 11660304 Dry powder treprostinil for the treatment of pulmonary hypertension

0

US Patent 11672775 Treprostinil prodrugs

0

US Patent 11744835 Dry powder treprostinil for the treatment of pulmonary hypertension

US Patent 11744836 Dry powder treprostinil for the treatment of pulmonary hypertension

Patent Primary Examiner

Jeffrey S Lundgren

0

Patent abstract

Treprostinil can be administered using a metered dose inhaler. Such administration provides a greater degree of autonomy to patients. Also disclosed are kits that include a metered dose inhaler containing a pharmaceutical formulation containing treprostinil.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9358240 Treprostinil administration by inhalation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool